U.S. stocks opened higher on Wednesday as traders monitor the latest developments in the Middle East and brace for the Federal Reserve’s latest rate policy decision.
The Dow Jones Industrial Average hovered around the flatline. The S&P 500 gained 0.1% along with the Nasdaq Composite.
Regencell Bioscience shares pulled back 23% in morning trading. The company’s year to date performance is off the charts too, having risen 59,900% in 2025. Its current market value of $36 billion tops Lululemon, eBay and Kraft Heinz. The shares traded for pennies at one point in the past one year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。